Innate Pharma (PK) Stock Quote IPHYF - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.20

Bid

2.58

Ask

3.17

Volume

0.00 Day's Range 0.00

2.13 52 Week Range 3.37

Market Cap

212.663M

Previous Close

2.20

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,533

Shares Outstanding

80,860,563

Dividend Yield

PE Ratio

-28.10

Earnings Per Share (EPS)

-0.09

Revenue

61.64M

Net Profit

-7.57M

Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by enhancing the capability of the body's own immune cells to recognize and kill cancer cells. The Company has pioneered the development of antibodies that block inhibitory checkpoint receptors on... Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by enhancing the capability of the body's own immune cells to recognize and kill cancer cells. The Company has pioneered the development of antibodies that block inhibitory checkpoint receptors on NK cells. Today, Innate Pharma has three first-in-class antibodies in clinical development in immuno-oncology and a pipeline of preclinical candidates to novel targets and mechanisms. Its innovative approach has translated into alliances with leaders in the biopharmaceutical industry such as AstraZeneca, Bristol-Myers Squibb, Novo Nordisk A/S and Sanofi. Based in Marseille, France, Innate Pharma had 122 employees as at March 31, 2016. The company is listed on Euronext Paris. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

1970

Innate Pharma (PK) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker IPHYF. The last closing price for Innate Pharma (PK) was $2.20. Over the last year, Innate Pharma (PK) shares have traded in a share price range of $ 2.13 to $ 3.37.

Innate Pharma (PK) currently has 80,860,563 shares outstanding. The market capitalization of Innate Pharma (PK) is $212.66 million. Innate Pharma (PK) has a price to earnings ratio (PE ratio) of -28.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0.07	3.28638497653	2.13	2.2	2.13	4033	2.18842975	CS
12	-0.32	-12.6984126984	2.52	2.65	2.13	1533	2.23149275	CS
26	-0.24	-9.83606557377	2.44	2.895	2.13	1083	2.31793939	CS
52	-0.9	-29.0322580645	3.1	3.37	2.13	756	2.44959585	CS
156	-1.46	-39.8907103825	3.66	11	1.93	1662	4.70106401	CS
260	-4.41	-66.7170953101	6.61	11	1.93	1596	5.15531038	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STSSSharps Technology Inc	$ 0.562 (162.25%)	227.22M
INSMInsmed Inc	$ 46.525 (111.48%)	20.66M
PEGYPineapple Energy Inc	$ 0.3279 (84.11%)	500.99M
CALTCalliditas Therapeutics AB	$ 38.04 (69.67%)	140.4k
GVVisionary Holdings Inc	$ 0.309 (54.50%)	6.38M
APDNApplied DNA Sciences Inc	$ 0.645 (-67.59%)	3.4M
MRAIMarpai Inc	$ 0.8651 (-55.41%)	523.57k
SHOTWSafety Shot Inc	$ 0.1638 (-50.14%)	18.92k
LUCYInnovative Eyewear Inc	$ 0.5382 (-45.25%)	31.66M
TOIIWOncology Institute Inc	$ 0.026 (-41.31%)	39.36k
PEGYPineapple Energy Inc	$ 0.3279 (84.11%)	500.99M
STSSSharps Technology Inc	$ 0.562 (162.25%)	227.22M
CRKNCrown Electrokinetics Corporation	$ 0.11015 (9.06%)	161.44M
GWAVGreenwave Technology Solutions Inc	$ 0.07785 (-8.30%)	150.15M
OBLGOblong Inc	$ 0.2392 (35.91%)	121.1M